|Articles|September 16, 2015

Dominant Strain of Drug-Resistant MRSA Decreases in Hospitals but Persists in the Community

This scanning electron micrograph (SEM) depicted numerous clumps of methicillin-resistant Staphylococcus aureus bacteria, commonly referred to by the acronym, MRSA; Magnified 2381x. Recently recognized outbreaks, or clusters of MRSA in community settings have been associated with strains that have some unique microbiologic and genetic properties, compared with the traditional hospital-based MRSA strains, which suggests some biologic properties, e.g., virulence factors like toxins, may allow the community strains to spread more easily, or cause more skin disease. A common strain named USA300-0114 has caused many such outbreaks in the United States. Image courtesy of the CDC

The incidence of the most common strain of methicillin-resistant Staphylococcus aureus (MRSA) infections has decreased in hospital-onset cases, but has failed to decline in the broader community, according to new research published online today in the journal Infection Control & Hospital Epidemiology.

The USA 300 strain of MRSA, has become prevalent in both communities and healthcare institutions. "In looking at risk factors for hospital or community-onset USA 300, current or former drug use was a strong predictor for acquiring this strain of bacteria," according to Kyle J. Popovich, MD, MS, the lead author of the study and Assistant Professor in the Section of Infectious Diseases, Rush University Medical Center, Chicago.

In the past 15 years, MRSA infections have evolved as the bacterium emerged as a significant pathogen in the community and hospitals in the U.S. Researchers studied 1,015 cases of Staphylococcus aureus bacterial bloodstream infections over a six-year period at a Chicago "safety net" hospital. The study found that more than half of hospital-acquired cases were due to the USA 300 strain.

Recent national surveillance has suggested a decrease in the incidence of invasive hospital-acquired MRSA infections during the past decade, and researchers said their findings reaffirmed that observation in the Chicago region.

"Decreases in hospital-onset MRSA BSIs may be due to substantial efforts aimed to reduce healthcare-associated infection," says Popovich. "Enhanced prevention efforts in the community for certain populations, such as those engaging in illicit drug use, may be necessary to further curb the spread of invasive MRSA infections."

Reference: Yoona Rhee, Alla Aroutcheva, Bala Hota, Robert A. Weinstein, Kyle J. Popovich. "Evolving Epidemiology of Staphylococcus aureus Bacteremia." Web (Sept. 16, 2015).

Source: Society for Healthcare Epidemiology of America


Related to this article

Water  (Adobe Stock 456102510 by stockphoto-graf)
Understanding current water quality is a starting point for ST108 implementation. John Kimsey, vice president of processing optimization and customer success for STERISS, spoke about his HSPA presentation on assessing readiness, distinguishing system qualification from routine testing, and understanding where water samples should be collected.
Image of Pathogens flying   (Adobe Stock weerasak)
Behind every landmark in infection prevention, from antimicrobial stewardship guidelines to the COVID-19 town halls that reached flight attendants and teachers, is a generation of physician-scientists who led SHEA through crises, organizational change, and scientific breakthroughs. Infection Control Today traces 30 years of SHEA presidents and the lasting mark they left on the field.
AORN26 New Orleans 2026  (Adobe Stock)
Missing instruments and processing delays can strain OR–SPD relationships. At AORN 2026, John Kimsey, vice president of processing optimization and customer success for STERIS, discusses understanding root causes, exploring off-site reprocessing for ambulatory surgical centers, and using hands-on simulation to help surgical teams see sterile processing from a different perspective.